Gene Expression in Oligodendroglial Tumors
Background: Oligodendroglial tumors with 1p/19q loss are more likely to be chemosensitive and have longer survival than those with intact 1p/19q, but not all respond to chemotherapy, warranting investigation of the biological basis of chemosensitivity.
Saved in:
Main Authors: | Elisabeth J. Shaw, Brian Haylock, David Husband, Daniel du Plessis, D. Ross Sibson, Peter C. Warnke, Carol Walker |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2010-01-01
|
Series: | Analytical Cellular Pathology |
Online Access: | http://dx.doi.org/10.3233/ACP-CLO-2010-0533 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Oligodendroglial heterogeneity in health, disease, and recovery: deeper insights into myelin dynamics
by: Pieter-Jan Serneels, et al.
Published: (2025-11-01) -
Glioblastomas with Oligodendroglial Component – Common Origin of the Different Histological Parts and Genetic Subclassification
by: Barbara Klink, et al.
Published: (2010-01-01) -
Long-term tracking of neural and oligodendroglial development in large-scale human cerebral organoids by noninvasive volumetric imaging
by: Sangjun Park, et al.
Published: (2025-01-01) -
Spontaneous high clonal expansion of Wilms’ tumor gene 1-specific cytotoxic T-lymphocytes in patients with Wilms’ tumor gene 1-expressing solid tumor
by: Soyoko Morimoto, et al.
Published: (2024-11-01) -
Microarray Gene Expression Analysis of Murine Tumor Heterogeneity Defined by Dynamic Contrast-Enhanced MRI
by: Nick G. Costouros, et al.
Published: (2002-07-01)